Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 3/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | BAX | Q07812 | 1/20 | 0.42 |
| ▸ | PARG | Q86W56 | 1/20 | 0.42 |
| ▸ | STK39 | Q9UEW8 | 1/20 | 0.42 |
| ▸ | PNLIP | P16233 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304918 | 0.82 | CYP1A2 (0.48) | ALDH1A1NPSR1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9768120 | 0.81 | LTA4H (0.55) | ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL10932438 | 0.81 | CXCL8 (0.45) | ALDH1A1TTRTSHRMEN1KMT2A | |
| SCHEMBL10437110 | 0.79 | AKR1B1 (0.52) | ALDH1A1NPSR1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL435162 | 0.79 | AKR1B1 (0.68) | ALDH1A1NPSR1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL4655458 | 0.78 | DPP4 (0.58) | ALDH1A1NPSR1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL29542318 | 0.76 | AKR1B1 (0.47) | ALDH1A1NPSR1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2916124 | 0.74 | LTA4H (0.52) | ALDH1A1TTRDPP4LTA4HNR1H2 | |
| SCHEMBL5180281 | 0.74 | TTR (0.49) | ALDH1A1NPSR1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL663380 | 0.74 | CYP3A4 (0.46) | ALDH1A1NPSR1CYP3A4LTA4HNR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267710-A1 | A PROCESS OF REMOVING MICROORGANISM FROM AN ARTICLE OF CLOTHING | The Procter & Gamble Company (US) | 2023-11-01 | — | — | EP | claimed |
| WO-2022134891-A1 | A PROCESS OF REMOVING MICROORGANISM FROM AN ARTICLE OF CLOTHING | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-30 | — | — | WO | claimed |
| EP-3568011-B1 | BIOFILM TARGETING MICROCAPSULE CARRYING A NON-VOLATILE FUNCTIONAL MATERIAL | UNILEVER IP HOLDINGS B V (NL) | 2021-10-13 | — | — | EP | claimed |
| EP-3568011-A1 | BIOFILM TARGETING MICROCAPSULE CARRYING A NON-VOLATILE FUNCTIONAL MATERIAL | Unilever PLC (GB) | 2019-11-20 | — | — | EP | claimed |
| US-20190343117-A1 | BIOFILM TARGETING MICROCAPSULE CARRYING A NON-VOLATILE FUNCTIONAL MATERIAL | CONOPCO, INC., D/B/A UNILEVER (US) | 2019-11-14 | — | — | US | claimed |
| WO-2019071500-A1 | ANTI-MICROBIAL LAUNDRY DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2019-04-18 | — | — | WO | claimed |
| WO-2018130395-A1 | BIOFILM TARGETING MICROCAPSULE CARRYING A NON-VOLATILE FUNCTIONAL MATERIAL | UNILEVER PLC (GB) | 2018-07-19 | — | — | WO | claimed |
| EP-2838982-B9 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2017-06-14 | — | — | EP | claimed |
| EP-2838982-B1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2015-09-23 | — | — | EP | claimed |
| EP-2838982-A1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | Unilever PLC (GB) | 2015-02-25 | — | — | EP | claimed |
| WO-2013156371-A1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2013-10-24 | — | — | WO | claimed |
| WO-2013025435-A1 | PACKAGED FABRIC CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-21 | — | — | WO | claimed |
| EP-4291626-A1 | ANTI-MICROBIAL COMPOSITION | The Procter & Gamble Company (US) | 2023-12-20 | — | — | EP | disclosed |
| EP-4168472-A1 | AMPHIPHILIC ALKOXYLATED POLYETHYLENE/-PROPYLENE IMINE COPOLYMERS FOR MULTI-BENEFIT DETERGENT FORMULATIONS | BASF SE (DE) | 2023-04-26 | — | — | EP | disclosed |
| EP-4162017-A1 | PARTICULATE LAUNDRY ADDITIVE | The Procter & Gamble Company (US) | 2023-04-12 | — | — | EP | disclosed |
| EP-3554232-B1 | BIOCIDAL COMPOSITION FOR USE IN A LAUNDRY WASHING PROCESS | UNILEVER IP HOLDINGS B V (NL) | 2023-01-04 | — | — | EP | disclosed |
| US-20060115440-A1 | Silver dihydrogen citrate compositions | PURE BIOSCIENCE | 2006-06-01 | — | — | US | disclosed |
| WO-2006051048-A1 | ANTIMICROBIAL POLYMER COMPOSITIONS HAVING IMPROVED DISCOLORATION RESISTANCE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-05-18 | — | — | WO | disclosed |
| EP-1057856-B1 | Process to make biocide plastics | CIBA SC HOLDING AG (CH) | 2004-12-01 | — | — | EP | disclosed |
| EP-1057856-A1 | Process to make biocide plastics | Ciba SC Holding AG (CH) | 2000-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060115440-A1 | Silver dihydrogen citrate compositions | IDH1, DSG1, SUCLG1 | ALDH1A1 1006/4885NPSR1 3612/4885CYP1A2 2175/4885 |
| US-20190343117-A1 | BIOFILM TARGETING MICROCAPSULE CARRYING A NON-VOLATILE FUNCTIONAL MATERIAL | ITGA5, MLEC, FUT5 | ALDH1A1 3579/4885NPSR1 2177/4885CYP1A2 3906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.